Drug shortages homepage
Welcome to Drug Shortages Canada, the website for mandatory reporting of drug shortages and discontinuations by market authorization holders. Anyone can search the database of shortage and discontinuation reports. More information can be found on the About & Resources Page.
Early reporting of shortages and discontinuations provides Health Canada, provincial/territorial governments, drug supply chain stakeholders, and health professionals details needed to help them monitor and manage supply. Shortages can be caused by many factors. Some last longer and are more complex than others. Because companies have to report every time they cannot fully meet demand, not all of the reports on this site are cause for concern at the patient level. Most are successfully managed before they impact patients.
The shortage database has a flag that indicates ones that are Tier 3 drug shortages, which are those that could potentially have the highest impact on Canada's drug supply and health care system. A Tier 3 designation is decided by the Tier Assignment Committee (TAC), composed of federal and provincial/territorial governments, healthcare professionals, and industry stakeholders.
Ensuring people can get the medicines they need is a top priority for Health Canada. Health Canada works closely with many partners to prevent shortages, mitigate their impacts, and help resolve them when they occur.
If you would like to know more about shortages like why they happen, how long they last, the actions being taken to reduce impacts on Canadians, and actions you can take if a drug you use is in shortage, please consult the information on Canada.ca.
Below are the newest shortage and discontinuation reports and updates to existing ones.
LEGEND
!!T3 denotes an actual Tier 3 shortage/discontinuation
!T3 denotes an anticipated Tier 3 shortage/discontinuation
Shortage Reports
Brand name | Company Name | Status | Strength | Update | Date Updated | View Report |
---|---|---|---|---|---|---|
FROVA | ENDO PHARMACEUTICALS INC. | Resolved | 2.5MG | Updated Report | 2024-06-17 | 192129 |
PRAXBIND | BOEHRINGER INGELHEIM (CANADA) LTD LTEE | Actual shortage | 50MG | Updated Report | 2024-06-17 | 230064 |
ATIVAN | PFIZER CANADA ULC | Actual shortage | 1MG | Updated Report | 2024-06-17 | 210722 |
COSOPT PRESERVATIVE-FREE | ELVIUM LIFE SCIENCES | Anticipated shortage | 5MG 20MG | New Report | 2024-06-17 | 230800 |
STERILE WATER FOR IRRIGATION, USP | BAXTER CORPORATION | Actual shortage | 100% | Updated Report | 2024-06-17 | 188299 |
STERILE WATER FOR IRRIGATION, USP | BAXTER CORPORATION | Actual shortage | 100% | Updated Report | 2024-06-17 | 189568 |
TIMOPTIC | ELVIUM LIFE SCIENCES | Anticipated shortage | 0.5% | New Report | 2024-06-17 | 230791 |
PRO-VALACYCLOVIR | PRO DOC LIMITEE | Actual shortage | 500MG | New Report | 2024-06-17 | 230788 |
!!T3 VITAMIN B1 | SANDOZ CANADA INCORPORATED | Actual shortage | 100MG | Updated Report | 2024-06-17 | 219763 |
JAMP DARIFENACIN | JAMP PHARMA CORPORATION | Actual shortage | 15MG | Updated Report | 2024-06-17 | 223959 |
JAMP DARIFENACIN | JAMP PHARMA CORPORATION | Actual shortage | 7.5MG | Updated Report | 2024-06-17 | 223940 |
HYDROMORPHONE HYDROCHLORIDE INJECTION USP | PFIZER CANADA ULC | Resolved | 10MG | Updated Report | 2024-06-17 | 226090 |
SANDOZ SOLIFENACIN | SANDOZ CANADA INCORPORATED | Actual shortage | 5MG | Updated Report | 2024-06-17 | 228426 |
SANDOZ TIMOLOL | SANDOZ CANADA INCORPORATED | Anticipated shortage | 0.5% | New Report | 2024-06-17 | 230771 |
SANDOZ RIVASTIGMINE | SANDOZ CANADA INCORPORATED | Anticipated shortage | 1.5MG | New Report | 2024-06-17 | 230768 |
SANDOZ PIRFENIDONE CAPSULES | SANDOZ CANADA INCORPORATED | Anticipated shortage | 267MG | New Report | 2024-06-17 | 230763 |
DESFERAL 500MG | NOVARTIS PHARMACEUTICALS CANADA INC | Actual shortage | 500MG | Updated Report | 2024-06-17 | 222962 |
MOUNJARO | ELI LILLY CANADA INC | Actual shortage | 5MG | Updated Report | 2024-06-17 | 210452 |
SANDOZ LOSARTAN | SANDOZ CANADA INCORPORATED | Anticipated shortage | 50MG | New Report | 2024-06-17 | 230755 |
MOUNJARO | ELI LILLY CANADA INC | Actual shortage | 2.5MG | Updated Report | 2024-06-17 | 210449 |
SANDOZ LOSARTAN | SANDOZ CANADA INCORPORATED | Anticipated shortage | 50MG | New Report | 2024-06-17 | 230751 |
SANDOZ ATORVASTATIN | SANDOZ CANADA INCORPORATED | Anticipated shortage | 40MG | New Report | 2024-06-17 | 230748 |
SANDOZ TOLTERODINE LA | SANDOZ CANADA INCORPORATED | Actual shortage | 4MG | Updated Report | 2024-06-17 | 228430 |
SANDOZ TIMOLOL | SANDOZ CANADA INCORPORATED | Actual shortage | 0.25% | Updated Report | 2024-06-17 | 225972 |
SANDOZ PIRFENIDONE TABLETS | SANDOZ CANADA INCORPORATED | Actual shortage | 801MG | Updated Report | 2024-06-17 | 224642 |
ESTRADOT 25 | SANDOZ CANADA INCORPORATED | Actual shortage | 25MCG | Updated Report | 2024-06-17 | 223191 |
SANDOZ DICLOFENAC RAPIDE | SANDOZ CANADA INCORPORATED | Actual shortage | 50MG | Updated Report | 2024-06-17 | 222606 |
TEVA-RIVAROXABAN | TEVA CANADA LIMITED | Resolved | 20MG | Updated Report | 2024-06-17 | 227456 |
TEVA-AMPHETAMINE XR | TEVA CANADA LIMITED | Resolved | 20MG | Updated Report | 2024-06-17 | 224904 |
SANDOZ DEFERASIROX (TYPE J) | SANDOZ CANADA INCORPORATED | Actual shortage | 360MG | Updated Report | 2024-06-17 | 225962 |
OCTREOTIDE FOR INJECTABLE SUSPENSION | TEVA CANADA LIMITED | Resolved | 10MG | Updated Report | 2024-06-17 | 166969 |
!!T3 SANDOZ-CARBAMAZEPINE CR | SANDOZ CANADA INCORPORATED | Actual shortage | 400MG | Updated Report | 2024-06-17 | 225212 |
VISTITAN | SANDOZ CANADA INCORPORATED | Actual shortage | 0.03% | Updated Report | 2024-06-17 | 221377 |
SANDOZ OLMESARTAN | SANDOZ CANADA INCORPORATED | Actual shortage | 20MG | Updated Report | 2024-06-17 | 224166 |
SANDOZ ATORVASTATIN | SANDOZ CANADA INCORPORATED | Actual shortage | 20MG | Updated Report | 2024-06-17 | 226664 |
INHIBACE PLUS | CHEPLAPHARM ARZNEIMITTEL GMBH | Anticipated shortage | 12.5MG 5MG | New Report | 2024-06-17 | 230712 |
KINEVAC | BRACCO IMAGING CANADA | Actual shortage | 5MCG | Updated Report | 2024-06-17 | 197753 |
APO-PREGABALIN | APOTEX INC | Actual shortage | 150MG | Updated Report | 2024-06-16 | 216726 |
TECHNESCAN MAG3 | CURIUM CANADA INC | Actual shortage | 1MG | Updated Report | 2024-06-15 | 229736 |
NITROLINGUAL PUMPSPRAY | SANOFI-AVENTIS CANADA INC | Resolved | 0.4MG | Updated Report | 2024-06-15 | 186618 |
MYCOPHENOLATE MOFETIL FOR INJECTION, USP | ACCORD HEALTHCARE INC | Actual shortage | 500MG | Updated Report | 2024-06-15 | 207554 |
SOLU-MEDROL | PFIZER CANADA ULC | Resolved | 1G | Updated Report | 2024-06-15 | 220618 |
CASPOFUNGIN FOR INJECTION | JUNO PHARMACEUTICALS CORP. | Actual shortage | 70MG | Updated Report | 2024-06-15 | 230498 |
CASPOFUNGIN FOR INJECTION | JUNO PHARMACEUTICALS CORP. | Actual shortage | 50MG | Updated Report | 2024-06-15 | 230495 |
APO-DEXLANSOPRAZOLE | APOTEX INC | Actual shortage | 30MG | Updated Report | 2024-06-15 | 230576 |
APO-DEXLANSOPRAZOLE | APOTEX INC | Actual shortage | 60MG | Updated Report | 2024-06-15 | 230579 |
NYADERM | TARO PHARMACEUTICALS INC | Actual shortage | 100000UNIT | New Report | 2024-06-14 | 230685 |
NYADERM | TARO PHARMACEUTICALS INC | Actual shortage | 100000UNIT | New Report | 2024-06-14 | 230682 |
TARO-LURASIDONE | TARO PHARMACEUTICALS INC | Actual shortage | 120MG | New Report | 2024-06-14 | 230679 |
TARO-LURASIDONE | TARO PHARMACEUTICALS INC | Actual shortage | 60MG | Updated Report | 2024-06-14 | 230675 |
Discontinuation Reports
Brand name | Company Name | Status | Strength | Update | Date Updated | View Report |
---|---|---|---|---|---|---|
NAPROXEN - 500 | PRO DOC LIMITEE | To be discontinued | 500MG | New Report | 2024-06-17 | 230716 |
NAPROXEN-375 | PRO DOC LIMITEE | To be discontinued | 375MG | New Report | 2024-06-17 | 230710 |
NAPROXEN - 250 | PRO DOC LIMITEE | To be discontinued | 250MG | New Report | 2024-06-17 | 230707 |
GLYBURIDE | PRO DOC LIMITEE | To be discontinued | 5MG | New Report | 2024-06-17 | 230704 |
GLYBURIDE | PRO DOC LIMITEE | To be discontinued | 2.5MG | New Report | 2024-06-17 | 230701 |
FOSRENOL | TAKEDA CANADA INC | Discontinued | 500MG | Updated Report | 2024-06-10 | 228178 |
GLUCONORM 2.0MG | NOVO NORDISK CANADA INC | To be discontinued | 2.0MG | Updated Report | 2024-06-05 | 201489 |
ISENTRESS | MERCK CANADA INC | To be discontinued | 100MG | Updated Report | 2024-06-04 | 204160 |
PRO-DESVENLAFAXINE | PRO DOC LIMITEE | Discontinued | 100MG | New Report | 2024-06-04 | 229623 |
PRO-DESVENLAFAXINE | PRO DOC LIMITEE | Discontinued | 50MG | New Report | 2024-06-04 | 229620 |